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Human breast milk exosomes accelerate mouse
wound healing
L Gardeazabal1 L Yndriago1 I Prieto1 A Crespo-Barreda2
P Martin-Duque2 J Aldazabal3 J Paredes3 A Izeta1 3
1: I.I.S. Biodonostia 2: Instituto Aragonés de Ciencias de la
Salud (IACS/IIS Aragón) 3: Universidad de Navarra
The healing of cutaneous wounds is a very efficient process
despite being very complex. Under certain pathological con-
ditions healing may be impaired, prolonging the healing pro-
cess and eventually leading to medical intervention and the
chronicity of the wound. Exosomes are secreted extracellular
vesicles present in biological fluids where they play a key role
in intercellular communication at the tissue, organ and organ-
ismal levels. Given that human breast milk contains abundant
maternal extracellular vesicles (MEVs) with pro-regenerative
and immunomodulatory properties, the aim of the present study
was to evaluate if topical application of MEVs into open wounds
would be beneficial for healing. Full-thickness excision wounds
of 4-mm diameter were created in the dorsal skin of C57BL/6
mice and topical application of 20 micrograms of human MEV
isolated at weeks 9, 11, 12 and 15 postpartum of breastfeeding
were placed onto the open wounds. Control wounds were
vehicle-treated. Macroscopic measurements up to 7 days post-
wounding revealed that the area of the wound treated with MEV
significantly decreased compared with controls. Histological
analyses at day 7 post-wounding showed no differences in the
granulation tissue area between groups. Nevertheless, dermal
integrity of the wounds appeared to vary under MEV treatments
isolated at different breastfeeding weeks. Our preliminary re-
sults suggest that MEV treatment of different breastfeeding
weeks may induce a faster wound closure but also granulation
tissue aberration.
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Development of matrixes and devices on the basis
of inert materials by the method of ion-beam
treatment to prototype cells and medical targets
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Matrix materials are in demand and promising in the field of
cellular technologies. A properly created matrix will not be an inert
environment, but an active medium regulating the basic processes
of cell life. Created a biomatrix based on inert material for the
cultivation of cells from various sources. In the course of the work,
factors affecting the increase in adhesion properties were identi-
fied, the substrate toxicity and oncogenicity were excluded, the
growth of mouse hepatocytes, human fibroblasts and Candida al-
bicans was analyzed on this surface. It is proved: the effectiveness
of modifying the surface of the glass to improve the adhesive
properties, thus, an increase in biomass in a shorter period of time,
the formation of a monolayer of cells. Using scanning electron
microscopy, it was found that the 2D matrix has an ordered cel-
lular structure that affects the increased adhesive properties. The
2D matrix is not cytotoxic and oncogenic. Hepatocytes of mice, on
a 2D-matrix, are adsorbed in an amount (2.8 – 0.2) times higher
than on a smooth glass. On the treated glass ion formed cell ag-
gregates. The number of human fibroblasts adsorbed on a 2D-
matrix is (1.5 – 0.5) times the number of cells than on a smooth
glass. Fibroblasts adsorbed on modified glass have a normal con-
figuration for this type of cell. Candida albicans cells are 5 times
more actively adsorbed on the modified glass than on the control
glass. Hepatocyte extract of mice incubated on modified glass
contains protein fractions with molecular weights of 30, 43, and
120 kDa compared with the control.
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Target optimized variant of CRISPR associated
nuclease enables allele-specific knock out of
ELANE-related neutropenia
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We present here a novel and broad approach for allele-specific
CRISPR gene editing which allows the targeting of different
mutated alleles of a disease-associated gene using one CRISPR
composition. This approach opens up unlimited opportunities for
gene editing therapy in cases of dominant negative mutations,
compound heterozygous mutations and haploinsufficiency. First,
we analyze human haplotypes and identify either a single nu-
cleotide polymorphism (SNP) or several SNPs that are predicted
to be associated with most of the known mutated alleles. Then,
we design a CRISPR based gene editing strategy targeting the
SNP and optimize a CRISPR associated nuclease (CAS) for that
sequence to enable editing only at the desired alleles. We
demonstrate the utility of this approach for knocking out mutated
alleles of ELANE. Heterozygous mutation in ELANE causes the
majority of Severe Congenital Neutropenia (SCN). Over 100
heterozygous mutations in ELANE associate with the disease.
We identified three SNPs that can be linked with the majority of
mutated alleles and designed CRISPR based strategies to knock
out these alleles. Then, we used our directed-evolution platform
to optimize a CAS nuclease to effectively and specifically cleave
at the SNPs. The optimized specificity of the nuclease allows the
allele specific editing. Finally, we show that electroporation of
human CD34+ cells with the optimized CRISPR composition
knocked out the mutated ELANE allele and the edited cells
mature to active neutrophils.
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In vivo genome editing of hAPOC3 in the liver of
APOC3 transgenic mouse leads to a robust and
stable reduction in serum triglyceride levels and
normalization of lipid profiles
L Wang1 I Muthuramu1 W Sharer2 J Smith2 V Bartsevich2
P Clark1 Z He1 H Zhang1 A Saveliev1 D Jantz2 J M Wilson
1: University of Pennsylvania 2: Precision BioSciences, Inc
Apolipoprotein C-III (APOC3) is a key player in triglyceride-
rich lipoprotein metabolism and is strongly associated with el-
evated plasma triglyceride (TG) levels. Patients with severe
hypertriglyceridemia are at risk for pancreatitis and cardiovas-
cular disease. Loss-of-function mutations in the APOC3 gene are
associated with low triglyceride levels and a decreased risk for
cardiovascular disease. Meganuclease-mediated genome editing
A178 POSTER PRESENTATIONS
D
ow
nl
oa
de
d 
by
 U
N
IV
 O
F 
Z
A
R
A
G
O
Z
A
 S
PA
IN
/S
w
et
s/
24
41
85
98
 f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
1/
25
/2
1.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
